Metraipolis › archive › dc_af7c678963fe
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis — Europe PMC PMID:35653330
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/35653330
- DOI
- 10.1371/journal.pone.0263595
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-18T09:52:43.498Z
- SHA-256 of the archived text
13e7756719ebf2558425d962bb86f0cdc9bdfdde5bf9242605577de28ea8c0ff- Stable URL of this page
https://metraipolis.com/documento/dc_af7c678963fe
How to cite
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis — Europe PMC PMID:35653330 — Europe PMC (en), https://europepmc.org/article/MED/35653330 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_af7c678963fe (Metraipolis archive dc_af7c678963fe, sha256 13e7756719ebf2558425d962bb86f0cdc9bdfdde5bf9242605577de28ea8c0ff)
BibTeX
@misc{dcaf7c678963fe,
title = {Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis — Europe PMC PMID:35653330},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/35653330},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_af7c678963fe; sha256 13e7756719ebf2558425d962bb86f0cdc9bdfdde5bf9242605577de28ea8c0ff},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/35653330. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: Neurological COVID-19 disease has been reported widely, but published studies often lack information on neurological outcomes and prognostic risk factors. We aimed to describe the spectrum of neurological disease in hospitalised COVID-19 patients; characterise clinical outcomes; and investigate factors associated with a poor outcome. Methods: We conducted an individual patient data (IPD) meta-analysis of hospitalised patients with neurological COVID-19 disease, using standard case definitions. We invited authors of studies from the first pandemic wave, plus clinicians in the Global COVID-Neuro Network with unpublished data, to contribute. We analysed features associated with poor outcome (moderate to severe disability or death, 3 to 6 on the modified Rankin Scale) using multivariable models. Results: We included 83 studies (31 unpublished) providing IPD for 1979 patients with COVID-19 and acute new-onset neurological disease. Encephalopathy (978 [49%] patients) and cerebrovascular events (506 [26%]) were the most common diagnoses. Respiratory and systemic symptoms preceded neurological features in 93% of patients; one third developed neurological disease after hospital admission. A poor outcome was more common in patients with cerebrovascular events (76% [95% CI 67-82]), than encephalopathy (54% [42-65]). Intensive care use was high (38% [35-41]) overall, and also greater in the cerebrovascular patients. In the cerebrovascular, but not encephalopathic patients, risk factors for poor outcome included breathlessness on admission and elevated D-dimer. Overall, 30-day mortality was 30% [27-32]. The hazard of death was comparatively lower for patients in the WHO European region. Interpretation: Neurological COVID-19 disease poses a considerable burden in terms of disease outcomes and use of hospital resources from prolonged intensive care and inpatient admission; preliminary data suggest these may differ according to WHO regions and country income levels. The different risk factors for encephalopathy and stroke suggest different disease mechanisms which may be amenable to intervention, especially in those who develop neurological symptoms after hospital admission. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2022 (prima pubblicazione 2022-06-02). Identificativi: PMID 35653330 · PMCID PMC9162376 · DOI 10.1371/journal.pone.0263595. Descrittori MeSH principali: Stroke; COVID-19. Pagina: https://europepmc.org/article/MED/35653330 — https://doi.org/10.1371/journal.pone.0263595. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-18T09:47:44.168Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.